1. Management of Advanced Pancreatic Adenocarcinoma

2. Pancreatic Cancer: A Lethal Malignancy

3. Management of Disease-Related Symptoms

4. Management of Disease-Related Symptoms (cont)

5. Management of Disease-Related Symptoms (cont)

6. Management of Disease-Related Symptoms (cont)

7. Management of Disease-Related Symptoms (cont)

8. Nursing Interventions: Palliative Care

9. Eating Serves Multiple Functions

10. Treatment of Metastatic Disease

11. First-Line Therapy: FOLFIRINOX

12. Adverse Effects of FOLFIRINOX and Gemcitabine as First-Line Therapy

13. Expected Response Rates With First-Line Therapies

14. Treatment of Metastatic Disease (cont)

16. Nanoliposomal Irinotecan

17. Nanoliposomal Irinotecan for Gemcitabine-Refractory Disease

18. Nanoliposomal Irinotecan in Patients Who Failed to Respond to Gemcitabine

19. NAPOLI-1 Trial: Subanalysis

20. Concluding Remarks

21. Abbreviations